GlassScriptPhysician profile
Lisa M Flower
NPI 1659394922
$11,414.04
in general payments reported to CMS, 2019-2025
38 companies · $1,441 in 2025
The $1,441 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,910 · 2020: $1,472 · 2021: $1,728 · 2022: $1,353 · 2023: $1,503 · 2024: $2,007 · 2025: $1,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,878 · Education: $73.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,877.57 |
| Education | $73.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,620.96 | 2020-2025 | |
| Novo Nordisk INC | $1,300.63 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,074.95 | 2019-2025 | Farxiga, Brilinta, Airsupra |
| Amgen INC. | $1,034.65 | 2019-2025 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $944.37 | 2019-2024 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $803.48 | 2019-2025 | |
| Astellas Pharma US INC | $677.56 | 2019-2025 | Veozah, Myrbetriq |
| Takeda Pharmaceuticals U.S.A., INC. | $634.26 | 2019-2025 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $575.91 | 2019-2025 | Jardiance, Tradjenta |
| Exact Sciences Corporation | $337.67 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $325.66 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $247.94 | 2020-2025 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $210.89 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $167.31 | 2019-2021 | |
| Allergan, INC. | $166.01 | 2020 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $146.31 | 2019-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Glaxosmithkline, LLC. | $146.09 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbott Laboratories | $144.09 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2, Amplatzer Amulet |
| Kowa Pharmaceuticals America, INC. | $143.22 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $136.54 | 2019-2025 | Camzyos |
| Eisai INC. | $114.07 | 2020-2022 | |
| Phathom Pharmaceuticals, INC. | $67.46 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $57.27 | 2020-2021 | |
| Medtronic, INC. | $49.68 | 2022-2025 | Inceptiv |
| Biohaven Pharmaceuticals, INC. | $35.92 | 2021 | |
| Novartis Pharmaceuticals Corporation | $31.52 | 2020-2025 | |
| Arbor Pharmaceuticals, INC. | $28.06 | 2022 | |
| Organon LLC | $21.82 | 2021 | |
| Xeris Pharmaceuticals, INC. | $20.50 | 2023 | Gvoke Hypopen |
| Ultragenyx Pharmaceutical INC. | $19.91 | 2022 | |
| Genentech USA, INC. | $19.47 | 2019 | |
| Mayne Pharma Commercial LLC | $18.43 | 2023 | |
| Philips North America LLC | $17.97 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $17.95 | 2022 | |
| Dexcom, INC. | $17.29 | 2021 | |
| Sunovion Pharmaceuticals INC. | $13.67 | 2021 | |
| Currax Pharmaceuticals LLC | $13.49 | 2021 | |
| Horizon Therapeutics Plc | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Flower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.